Hedge Fund and Insider Trading News: Anthony Scaramucci, Michael Burry, Bill Miller, Brevan Howard Asset Management, Engine No. 1, Bright Health Group Inc (BHG), J2 Global Inc (JCOM), and More

Page 2 of 2

The Pursuit of Perfect Neutrality (Hedge Nordic)
Stockholm (HedgeNordic) – Once every few years, a high-caliber Swedish money manager working in the world’s largest financial hubs of London and New York is returning to Sweden to start a new adventure on home turf. Jakob Nordestedt, who became a portfolio manager at the young age of 30 at HSBC in London and moved back to Stockholm in 2018, is now running a market-neutral strategy under the umbrella of Nordea Asset Management.

Brevan Howard Appoints Head of Crypto Venture Investments (Hedge Week)
Brevan Howard Asset Management LLP, a global alternative investment management platform, has appointed Colleen Sullivan, CEO and co-founder of CMT Digital, to lead the firm’s private and venture investment activities in crypto. Additionally, Sullivan is to chair the investment committee of a new strategy which will focus on the highly compelling and disruptive technologies in this asset class. Brevan Howard is also announcing the formation of BH Digital, a new division to manage cryptocurrency and digital assets.

Monday 9/13 Insider Buying Report: BHG, IMNM (Nasdaq.com)
On Wednesday, Bright Health Group’s, Manuel Kadre, made a $959,000 purchase of BHG, buying 100,000 shares at a cost of $9.59 each. Kadre was up about 6.5% on the buy at the high point of today’s trading session, with BHG trading as high as $10.21 in trading on Monday. Bright Health Group is trading up about 4.5% on the day Monday. Before this latest buy, Kadre bought BHG at 3 other times during the past twelve months, for a total cost of $692,025 at an average of $8.65 per share. And at Immunome, there was insider buying on Friday, by Director Michael Rapp who bought 45,950 shares for a cost of $18.07 each, for a trade totaling $830,449. Before this latest buy, Rapp bought IMNM on 3 other occasions during the past twelve months, for a total cost of $2.97M at an average of $15.59 per share. Immunome is trading up about 5.9% on the day Monday. So far Rapp is in the green, up about 10.4% on their purchase based on today’s trading high of $19.95.

Insider Trading: September 13, 2021 (BIV.com)
Insider Michael Robert Martin, director. Company: Aurinia Pharmaceuticals Inc. (Nasdaq:AUPH). Shares owned: 150,324. Trade date: August 26. Trade total: US$400,725. Trade: Sale of 22,500 shares at a price of US$17.81 per share. Insider Jerry Kroll, director. Company: Electrameccanica Vehicles Corp. (Nasdaq:SOLO). Shares owned: 1,700,069. Trade date: August 26, 27. Trade total: US$290,007. Trade: Sale of 83,696 shares at prices from US$3.46 to US$3.47 per share.

Notable Gevo Insider Makes $411.34 Thousand Sale (Benzinga)
Geoffrey T. Williams Jr., Vp-General Counsel And Secretary at Gevo (NASDAQ:GEVO), made a large insider sell on September 9, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that Jr. sold 51,316 shares of Gevo at a price of $8.02 per share. The total transaction amounted to $411,339. Following the transaction, Jr. still owns 370,135 shares of Gevo worth $2,450,293.

The Pres. & CFO of J2 Global (NASDAQ: JCOM) is Buying Shares (Analyst Ratings)
Yesterday, the Pres. & CFO of J2 Global (JCOM), Scott Turicchi, bought shares of JCOM for $1.55M. Following Scott Turicchi’s last JCOM Buy transaction on December 16, 2020, the stock climbed by 39.7%. This is Turicchi’s first Buy trade following 12 Sell transactions. Based on J2 Global’s latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $429 million and quarterly net profit of $15.72 million.

Barclay Hedge Fund Index up 1.23% in August, +10% YTD (Opalesque.com)
Opalesque Industry Update – The hedge fund industry generated an average return of 1.23% in August 2021, which may have pushed its winning streak into double-digits, according to the Barclay Hedge Fund Index compiled by BarclayHedge, a division of Backstop Solutions. For the year to date, the Barclay Hedge Fund Index was up 10.00%. 28 of 30 hedge fund subsectors tracked in the Barclay Hedge Fund Indices posted monthly gains in August, led by the Emerging Markets MENA Index which was up 3.54% and the Technology Index ahead 3.36%.








Page 2 of 2